Latest news
Jazz Acquires Actio Bioscience | PharmExec - Pharmaceutical ExecutivePharmaceutical Executive · Mon, 10 Aug 2026 18:37:55 GMTJazz Pharmaceuticals expands rare epilepsy pipeline with Actio Biosciences deal - European Pharmaceutical ReviewEuropean Pharmaceutical Review · Mon, 10 Aug 2026 16:17:36 GMTJazz expands epilepsy portfolio with buy of Actio Biosciences - The Pharma LetterThe Pharma Letter · Mon, 10 Aug 2026 15:16:17 GMTJazz bets on epilepsy treatment with up to $1.32 billion deal for Actio - ReutersReuters · Mon, 10 Aug 2026 15:11:12 GMTJazz commits up to $1.3B to buy Actio, bolster epilepsy pipeline - BioSpaceBioSpace · Mon, 10 Aug 2026 14:55:28 GMTJazz Pharmaceuticals to Acquire Actio Biosciences for $1.32 Billion - Pharmaceutical ExecutivePharmaceutical Executive · Mon, 10 Aug 2026 14:22:59 GMTJazz moves on Actio Bio for up to USD 1.3b to enter KCNT1-driven epilepsy market - AllSciAllSci · Mon, 10 Aug 2026 13:57:16 GMTJazz builds in epilepsy with $1.3bn Actio acquisition - pharmaphorumpharmaphorum · Mon, 10 Aug 2026 13:12:18 GMT